Health
Study identifies new therapeutic targets for treatment of obesity and type 2 diabetes – News-Medical.Net
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake.
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz Zentrum München, ETH Zurich and the German Center for Diabetes Research (DZD). The study, which has now been published in ‘Cell Metabolism’, identifies new targets for the development of a drug treatment for obesity and type 2 diabetes.
Dual-agonists targeting the receptors for Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic…
-
Noosa News22 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout
-
General22 hours agoMyanmar earthquake rescue efforts wind down as death toll hits 3,600
-
Noosa News23 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business22 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?